Veterinary diagnostics is one of the most consistently growing segments adjacent to human IVD — benefiting from rising pet ownership globally, premiumization of companion animal healthcare, and the expanding application of in-clinic diagnostic platforms in veterinary practice. IDEXX Laboratories dominates the companion animal diagnostics market with its IDEXX CATALYST and ProCyte systems, and the company's installed base of analyzers in veterinary clinics globally provides a powerful reagent rental revenue stream. Zoetis, Heska, and Antech compete in companion animal diagnostics, while bioMérieux, IDEXX, and Neogen lead food safety and agricultural diagnostic testing. The One Health paradigm — recognizing the interconnection between animal, human, and environmental health — is driving investment in zoonotic disease surveillance and antimicrobial resistance monitoring that spans both veterinary and human IVD.

This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.


Topics Covered
• Veterinary Diagnostics Market Size and Forecast 2025-2030 by Segment and Region
• Companion Animal Diagnostics — Chemistry, Hematology, Immunoassay, and Molecular Testing
• In-Clinic Diagnostics — IDEXX CATALYST, ProCyte, and In-House Platform Competition
• Reference Lab Veterinary Testing — IDEXX Reference Laboratories and Antech
• Livestock and Production Animal Diagnostics — Disease Surveillance and AMR Testing
• Food Safety IVD — Pathogen Detection, Mycotoxin, and Residue Testing
• Zoonotic Disease Diagnostics — Rabies, Brucella, Avian Influenza, and Emerging Pathogens
• Competitive Landscape — IDEXX, Zoetis, Heska, bioMérieux, Neogen, and QIAGEN
• Regional Analysis — Companion Animal Ownership and Vet Diagnostic Adoption Globally
• Investment and Partnership Opportunities — In-Clinic Platform and Food Safety Testing